{
    "2018-12-13": [
        [
            {
                "time": "",
                "original_text": "医药生物行业周报:仿制药高毛时代过去,集中度提升将催生新巨头",
                "features": {
                    "keywords": [
                        "医药生物",
                        "仿制药",
                        "高毛利",
                        "集中度提升",
                        "新巨头"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "被机构超级看好的成长股 未来3年净利增速超30%个股（名单）",
                "features": {
                    "keywords": [
                        "机构看好",
                        "成长股",
                        "净利增速",
                        "30%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}